FDA Clearance Tracker · P030050-S009
SCULPTRA AND SCULPTRA AESTHETIC
Last checked: Nov 20, 2026Latest source record: Dec 9, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Dec 9, 2011
Approved
Time to decision
368 days
Received Dec 6, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030050-S009
- Device name
- SCULPTRA AND SCULPTRA AESTHETIC
- Applicant
- Q-Med AB
- Applicant location
- Uppsala
- Received
- Dec 6, 2010
- Decided
- Dec 9, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030050
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR: 1) A REVISION OF SCULPTRA AND SCULPTRA AESTHETIC LABELING TO INCLUDE INFORMATION CONCERNING A PRECLINICAL IMAGING STUDY COMPLETED AS CONDITION OF APPROVAL; AND 2) TO REVISE THE STORAGE CONDITIONS PRESENTED IN YOUR PRODUCT LABEL.
Source documents
Other decisions for Q-Med AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Restylane® ContourPMA supplement
P140029-S054 · Decided Mar 20, 2026 · 239 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.